Patents law

This book provides practical and detailed account of all procedural aspects of the Unified Patent Court and Unitary Patent system.

Coalitions and Compliance examines how international changes can reconfigure domestic politics.

This volume tackles a quickly-evolving field of inquiry, mapping the existing discourse as part of a general attempt to place current developments in historical context; at the same time, breaking new ground in taking on novel subjects and pursuing fresh approaches.

Ideas are the fuel of industry and the entertainment business.

In recent years, business leaders, policymakers, and inventors have complained to the media and to Congress that today's patent system stifles innovation instead of fostering it.

This book analyses the gendered nature of patent law and the knowledge governance system it supports.

This book responds to the need to distinguish human creations from those produced by AI.

This book critiques the decision-making process in Article 53(a) of the European Patent Convention.

Tracing global histories of patenting, this book reveals the resilient diversity of patent systems, challenging the universality of ''intellectual property''.

Are innovation and creativity helped or hindered by our intellectual property laws?

This book evaluates issues and challenges emerging from the interaction between intellectual property (IP) and new technologies, namely artificial intelligence (AI), big data, social media, internet of things (IoT), metaverse, blockchain, video gaming, and voice cloning.

Exploring the relationship between competition law and technology pools, this book provides general-purpose details of the biotechnology patent pool scheme while discussing historical developments, approaches of the US Department of Justice, Federal Trade Commission, and the European Union Competition Commission via EU regulations.

This book provides practical and detailed account of all procedural aspects of the Unified Patent Court and Unitary Patent system.

The rise of China's economy has led to a substantial increase in disputes involving intellectual property rights, including patents.

On 17 December 2012, following a complex negotiation which lasted 12 years, the European Parliament adopted Regulations (EU) 1257/2012 and 1260/2012 and the text of the Agreement on a Unified Patent Court (UPC Agreement).

This book explores the question of whether software should be patented.

First published in 1998, this was the first book to present a comprehensive summary of both the global as well as institutional issues which are involved in biotechnology sharing.

Are innovation and creativity helped or hindered by our intellectual property laws?

A straightforward guide to inventing, patenting, and technology commercialization for scientists and engineers Although chemists, physicists, biologists, polymer scientists, and engineers in industry are involved in potentially patentable work, they are often under-prepared for this all-important field.

The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime.

A comprehensive review of Hong Kong''s pharmaceutical patent law that will influence debate and inform public policy.

A theoretical critique of the patent and innovation policy funnelled by intellectual property instruments towards developing countries.

This edition is fully updated to reflect the Digital Economy Act 2010 and changes to consumer protection law at EU level including the Unfair Commercial Practices Directive.

Publishing continues to be a major industry worldwide, and this book is designed to assist the thousands of entities that regularly contract into a variety of agreements and need advice in drafting or negotiating the best terms for a deal, or otherwise employing or understanding specific terms used.

This collection reflects on contemporary and contentious issues in international rulemaking in regards to pharmaceutical patent law.

This book evaluates issues and challenges emerging from the interaction between intellectual property (IP) and new technologies, namely artificial intelligence (AI), big data, social media, internet of things (IoT), metaverse, blockchain, video gaming, and voice cloning.

In the era of modern industrial regimes, the role of technology in tackling climate change is pivotal.

Patent Transactions in the Life Sciences is designed to provide guidance on the structure and detail of those agreements in the life sciences sector that are based on its most important assets - patents and know-how.

This book reflects on the development of Nigeria's intellectual property law and outlines the urgent need for reform.

Sharing biological resources—critical for new medicines and vaccines—has declined as countries and scientists dispute rights over research.

Intellectual Property in the Life Sciences: A Global Guide to Rights and Their Applications, 2nd Ed provides crucial guidance on all major IP issues affecting the life sciences sector.

For entrepreneurs, investors, creators, tinkers, and any business with products or processes that can be patented, Patents Demystified provides an easy-to-understand insider guide to patents, patent law, and the patent application process.

In September 2020 the UK signed its first major free trade deal as an independent country outside the EU, with Japan.

Although employers are required to pay compensation for employee inventions under the laws in many countries, existing legal literature has never critically examined whether such compensation actually gives employee inventors an incentive to invent as the legislature intends.

The chemicals, pharmaceuticals and biotechnology industries worldwide rely upon being able to patent inventions in order to protect investment in research and development, and to reap commercial rewards.

This book examines global health problems through the lens of public and international law, focusing on access to essential medicines.

This book analyses 4 central pieces of EU pharmaceutical regulation: the Orphan Drugs Regulation, the Paediatric Regulation, the Supplementary Protection Certificate Regulation, and the ATMP (Advanced Therapy Medicinal Products) Regulation.

A fundamental reassessment of the contribution of patenting to British industrialisation during the eighteenth and nineteenth centuries.

This book examines the development of the concept of intellectual property in the United States during the nineteenth century.

First published in 1998, this was the first book to present a comprehensive summary of both the global as well as institutional issues which are involved in biotechnology sharing.

This book highlights the special issues arising in obtaining, commercialising, enforcing or attacking intellectual property rights (including protection of regulatory data) in the pharmaceutical, biotechnology and chemical industries across the world's key jurisdictions.

The United States patent system has become sand rather than lubricant in the wheels of American progress.

Tracing global histories of patenting, this book reveals the resilient diversity of patent systems, challenging the universality of ''intellectual property''.

In the new 'knowledge-intensive economies' Intellectual assets increasingly play a key part on balance sheets.

A Practitioner's Guide to the Unified Patent Court and Unitary Patent provides practical and detailed advice on all aspects of the system for those using it.

This new edition is a comprehensive and practical guide to European patent law a 'ius commune'.

This book provides an overview of developments in personalized medicine patenting and explores its normative implications to suggest policies to best regulate it.

Inventor?